329 related articles for article (PubMed ID: 34407291)
1. The role of ferroptosis in melanoma.
Talty R; Bosenberg M
Pigment Cell Melanoma Res; 2022 Jan; 35(1):18-25. PubMed ID: 34407291
[TBL] [Abstract][Full Text] [Related]
2. Targeting ferroptosis as a cell death pathway in Melanoma: From molecular mechanisms to skin cancer treatment.
Manzari Tavakoli G; Mirzapour MH; Razi S; Rezaei N
Int Immunopharmacol; 2023 Jun; 119():110215. PubMed ID: 37094541
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis, pyroptosis and necroptosis in hepatocellular carcinoma immunotherapy: Mechanisms and immunologic landscape (Review).
Liu RJ; Yu XD; Yan SS; Guo ZW; Zao XB; Zhang YS
Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757345
[TBL] [Abstract][Full Text] [Related]
4. CAMKK2 Defines Ferroptosis Sensitivity of Melanoma Cells by Regulating AMPK‒NRF2 Pathway.
Wang S; Yi X; Wu Z; Guo S; Dai W; Wang H; Shi Q; Zeng K; Guo W; Li C
J Invest Dermatol; 2022 Jan; 142(1):189-200.e8. PubMed ID: 34242660
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity.
Tang R; Xu J; Zhang B; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
J Hematol Oncol; 2020 Aug; 13(1):110. PubMed ID: 32778143
[TBL] [Abstract][Full Text] [Related]
6. Harnessing the Potential of Non-Apoptotic Cell Death Processes in the Treatment of Drug-Resistant Melanoma.
Dong L; Vargas CPD; Tian X; Chu X; Yin C; Wong A; Yang Y
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373523
[TBL] [Abstract][Full Text] [Related]
7. Ferroptosis: a new unexpected chance to treat metastatic melanoma?
Gagliardi M; Saverio V; Monzani R; Ferrari E; Piacentini M; Corazzari M
Cell Cycle; 2020 Oct; 19(19):2411-2425. PubMed ID: 32816618
[TBL] [Abstract][Full Text] [Related]
8. Gambogenic acid induces ferroptosis in melanoma cells undergoing epithelial-to-mesenchymal transition.
Wang M; Li S; Wang Y; Cheng H; Su J; Li Q
Toxicol Appl Pharmacol; 2020 Aug; 401():115110. PubMed ID: 32533954
[TBL] [Abstract][Full Text] [Related]
9. Targeting ferroptosis in melanoma: cancer therapeutics.
Khorsandi K; Esfahani H; Ghamsari SK; Lakhshehei P
Cell Commun Signal; 2023 Nov; 21(1):337. PubMed ID: 37996827
[TBL] [Abstract][Full Text] [Related]
10. Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress.
Tsoi J; Robert L; Paraiso K; Galvan C; Sheu KM; Lay J; Wong DJL; Atefi M; Shirazi R; Wang X; Braas D; Grasso CS; Palaskas N; Ribas A; Graeber TG
Cancer Cell; 2018 May; 33(5):890-904.e5. PubMed ID: 29657129
[TBL] [Abstract][Full Text] [Related]
11. Understanding the Tumor Microenvironment in Melanoma Patients with In-Transit Metastases and Its Impacts on Immune Checkpoint Immunotherapy Responses.
Tian J; Quek C
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673829
[TBL] [Abstract][Full Text] [Related]
12. Immune Checkpoint Therapies for Melanoma.
Buchbinder EI
Hematol Oncol Clin North Am; 2021 Feb; 35(1):99-109. PubMed ID: 33759776
[TBL] [Abstract][Full Text] [Related]
13. New Therapeutic Approaches for Conjunctival Melanoma-What We Know So Far and Where Therapy Is Potentially Heading: Focus on Lymphatic Vessels and Dendritic Cells.
Peil J; Bock F; Kiefer F; Schmidt R; Heindl LM; Cursiefen C; Schlereth SL
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163401
[TBL] [Abstract][Full Text] [Related]
14. A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis.
Wang G; Xie L; Li B; Sang W; Yan J; Li J; Tian H; Li W; Zhang Z; Tian Y; Dai Y
Nat Commun; 2021 Sep; 12(1):5733. PubMed ID: 34593794
[TBL] [Abstract][Full Text] [Related]
15. Non-Apoptotic Cell Death Signaling Pathways in Melanoma.
Hartman ML
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340261
[TBL] [Abstract][Full Text] [Related]
16. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy.
Gao W; Wang X; Zhou Y; Wang X; Yu Y
Signal Transduct Target Ther; 2022 Jun; 7(1):196. PubMed ID: 35725836
[TBL] [Abstract][Full Text] [Related]
17. Combining BRAF/MEK Inhibitors with Immunotherapy in the Treatment of Metastatic Melanoma.
Ziogas DC; Konstantinou F; Bouros S; Theochari M; Gogas H
Am J Clin Dermatol; 2021 May; 22(3):301-314. PubMed ID: 33765322
[TBL] [Abstract][Full Text] [Related]
18. The engineered exosomes targeting ferroptosis: A novel approach to reverse immune checkpoint inhibitors resistance.
Chen A; Zhang W; Jiang C; Jiang Z; Tang D
Int J Cancer; 2024 Jul; 155(1):7-18. PubMed ID: 38533694
[TBL] [Abstract][Full Text] [Related]
19. Autophagy, anoikis, ferroptosis, necroptosis, and endoplasmic reticulum stress: Potential applications in melanoma therapy.
Ashrafizadeh M; Mohammadinejad R; Tavakol S; Ahmadi Z; Roomiani S; Katebi M
J Cell Physiol; 2019 Nov; 234(11):19471-19479. PubMed ID: 31032940
[TBL] [Abstract][Full Text] [Related]
20. New drug targets in metastatic melanoma.
Homet B; Ribas A
J Pathol; 2014 Jan; 232(2):134-41. PubMed ID: 24027077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
